advertisement
Wu J 65
Showing records 1 to 25 | Display all abstracts from Wu J104694 One-step high-throughput detection of low-abundance biomarker BDNF using a biolayer interferometry-based 3D aptasensor
Gao S
Biosensors & bioelectronics 2022; 215: 114566
104795 Effect of refractive status on retinal nerve fiber layer thickness in Chinese Population
Wu J
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 201-211
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Li F
Translational vision science & technology 2022; 11: 22
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Yang Z
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Han R
Frontiers in public health 2022; 10: 944967
104018 Recent developments of neuroprotective agents for degenerative retinal disorders
Ou K
Neural Regeneration Research 2022; 17: 1919-1928
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Yang Y
Frontiers in cell and developmental biology 2022; 10: 925835
104018 Recent developments of neuroprotective agents for degenerative retinal disorders
Li Y
Neural Regeneration Research 2022; 17: 1919-1928
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Cheng G
Frontiers in public health 2022; 10: 944967
104694 One-step high-throughput detection of low-abundance biomarker BDNF using a biolayer interferometry-based 3D aptasensor
Li Q
Biosensors & bioelectronics 2022; 215: 114566
104795 Effect of refractive status on retinal nerve fiber layer thickness in Chinese Population
Du Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 201-211
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Wu J
Frontiers in cell and developmental biology 2022; 10: 925835
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Wu J
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Pan J
Translational vision science & technology 2022; 11: 22
104795 Effect of refractive status on retinal nerve fiber layer thickness in Chinese Population
Lin C
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 201-211
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Yang D
Translational vision science & technology 2022; 11: 22
104694 One-step high-throughput detection of low-abundance biomarker BDNF using a biolayer interferometry-based 3D aptasensor
Zhang S
Biosensors & bioelectronics 2022; 215: 114566
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Lu W
Frontiers in cell and developmental biology 2022; 10: 925835
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Wu K
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104018 Recent developments of neuroprotective agents for degenerative retinal disorders
Liu L
Neural Regeneration Research 2022; 17: 1919-1928
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Zhang B
Frontiers in public health 2022; 10: 944967
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Dai Y
Frontiers in cell and developmental biology 2022; 10: 925835
104018 Recent developments of neuroprotective agents for degenerative retinal disorders
Li H
Neural Regeneration Research 2022; 17: 1919-1928
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Luo J
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Yang J
Frontiers in public health 2022; 10: 944967
